We serve Chemical Name:5-ethyl-2-picoline borane CAS:1014979-56-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-ethyl-2-picoline borane
CAS.NO:1014979-56-6
Synonyms:(5-Ethyl-2-methylpyridin-1-ium-1-yl)trihydroborate;5-ethyl-2-picolineborane
Molecular Formula:C8H11BN
Molecular Weight:131.99100
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:4.93000
Exact Mass:132.09800
LogP:1.57160
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (5-Ethyl-2-methylpyridin-1-ium-1-yl)trihydroborate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-ethyl-2-picolineborane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-ethyl-2-picolineborane Use and application,(5-Ethyl-2-methylpyridin-1-ium-1-yl)trihydroborate technical grade,usp/ep/jp grade.
Related News: In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of ��predictable�� clinical value for life-threatening diseases for which effective treatment is not immediately available. 5-ethyl-2-picoline borane manufacturer In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of ��predictable�� clinical value for life-threatening diseases for which effective treatment is not immediately available. 5-ethyl-2-picoline borane supplier Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added ��The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova. 5-ethyl-2-picoline borane vendor In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of ��predictable�� clinical value for life-threatening diseases for which effective treatment is not immediately available. 5-ethyl-2-picoline borane factory In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of ��predictable�� clinical value for life-threatening diseases for which effective treatment is not immediately available.
